Milestones:
 1990 
 -Divis Research Center (DRC) established. 
 1991-1993 
 -DRC successfully develops several commercial processes for
 intermediates and bulk actives and supplies to manufacturing majors.
 
 1994
 -Divis Research Center changes its name to Divis Laboratories Limited
 to reflect its growing area of operations and its plans to enter the
 manufacturing sector in the following year. 
 1995
 -Manufacturing Facility (Unit-1) at Choutuppal near Hyderabad starts
 operations. 
 
 1997 
 -SGS-Yarsley of U.K certifies Divis Laboratories as ISO-9002
 compliant. 
 1999
 -European Directorate gives a “Certificate of Suitability” (CoS) for
 Naproxen produced at Divis Laboratories. 
 2000
 -US-FDA inspects Divis Laboratories successfully SGS-Yarsley of U.K
 awards Divis the ISO 9001 Certification SGS International AG of
 Switzerland awards Divis the ISO-14001 Certification (for its
 efficient Environment Management Systems). 
 2001
 -BVQI of London awards Divis the OHSAS-18001 Certification (for its
 Occupational Health and Safety Management Systems). 
 2002
 -Divis commences the setting up of its 2nd Manufacturing Facility
 (Unit-2) at Chippada near Visakhapatnam.
 2003
 -Divis opens a new research center christened ‘DRC-Vizag’ for
 fundamental research in selected niche business core segments.
 -Went for IPO and listed on stock exchanges BSE, NSE and HSE. 
  -Divi's Laboratorie receives Certificate of Substantiability from
 the council of Europe
 
 -Appointed Mr A Narendra as Company Secretary & Compliance Officer of
 the company (in place of outgoing Company Secretary Mr P Sudarshan)
 who has joined the organization.
 
 2004
 
 - Divi'S Laboratories Limited has informed that the manufacturing
 facility of Divi's Labs at Choutuppal near Hyderabad was successfully
 inspected by US-FDA in May 2004.
 
 -US-FDA inspects the Choutuppal (Unit-1) for a second time. No 483. 
 
 2006
 
 -Delists equity shares form The Hyderabad Stock Exchange Ltd (HSE),
 Hyderabad with effect from March 29, 2006.
 
 -US-FDA inspects the Visakhapatnam(Unit-2) for the first time. 
 
 2007
 
 - The Company has splits its face value from Rs10/- to Rs2/-.
 
 2008
 -Third US-FDA inspection for Choutuppal(Unit-1).